artaratx.comContact us
About company
Provider and developer of a rare diseases therapeutics intended for rare gastrointestinal, metabolic, circulatory and neurological disorders. The company's lead asset is IV Choline Chloride, a therapeutic treatment for the orphan disease IFALD (Intestinal Failure Associated Liver Disease), which is a progressive, potentially fatal liver disease that afflicts people who survive on parenteral nutrition.
US
Unknown
Not verified company
